The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Agafonova Yu.A.

Center for Expertise and Quality Control of Medical Care

Fedyaev D.V.

Center for Expertise and Quality Control of Medical Care;
Russian Medical Academy of Continuous Professional Education;
Research Financial Institute

Omelyanovskiy V.V.

Center for Expertise and Quality Control of Medical Care;
Russian Medical Academy of Continuous Professional Education;
Research Financial Institute;
Semashko National Research Institute of Public Health

Snegovoy A.V.

Blokhin National Cancer Research Center;
Evdokimov Moscow State University of Medicine and Dentistry

Continuity of outpatient and inpatient drug supply of cancer patients — problems and solutions

Authors:

Agafonova Yu.A., Fedyaev D.V., Omelyanovskiy V.V., Snegovoy A.V.

More about the authors

Read: 4139 times


To cite this article:

Agafonova YuA, Fedyaev DV, Omelyanovskiy VV, Snegovoy AV. Continuity of outpatient and inpatient drug supply of cancer patients — problems and solutions. Medical Technologies. Assessment and Choice. 2021;43(3):37‑44. (In Russ.)
https://doi.org/10.17116/medtech20214303137

References:

  1. Mironova TK. The right to medical care and drug provision. Voprosy rossijskogo i mezhdunarodnogo prava. 2016;5:97-112. (In Russ.).
  2. Sistema okazaniya medicinskoj pomoshchi v Rossijskoj Federacii. Pod red. Omel’yanovskogo V.V. M.: Nauka; 2019. (In Russ).
  3. Tryakin AA, Besova NS, Volkov NM, Gladkov OA, Karaseva VV, Sakaeva DD, et al. Practical recommendations on the general principles of antitumor drug therapy. Zlokachestvennye opuholi. 2020;10(3s2-1):26-39. (In Russ.). https://doi.org/10.18027/2224-5057-2020-10-3s2—01
  4. DSM Group. Farmacevticheskij rynok Rossii 2019. Accessed January 25, 2021. (In Russ.). https://dsm.ru/docs/analytics/2019_Report_rus_2019.pdf
  5. L’gotnoe lekarstvennoe obespechenie v pervom kvartale 2020 goda. 04.06.20. Accessed January 25, 2021. (In Russ.). https://dsm.ru/news/1179/
  6. Omelyanovskiy VV, Maksimkina EA, Ivakhnenko OI, Avxentyeva MV, Sura MV, Khachatryan GR. Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871. Farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2020;13(2):113-123. (In Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.032
  7. Avxentyeva MV, Omelyanovskiy VV, Petrovskiy AV, Davydov MI, Zheleznyakova IA, Tyulyandin SA, et al. New Approaches to the Development of Diagnostic Related Groups for Cancer Pharmacotherapy in Russian Federation. Medicinskie tekhnologii. Ocenka i vybor. 2018;32(2):8-22. (In Russ.). https://doi.org/10.31556/2219-0678.2018.32.2.008-022
  8. Lazareva ML, Zheleznyakova IA, Avxentyeva MV, Fedyaev DV, Zuev AV, Ledovskikh YA, et al. Main Changes in the Model of Diagnosis-Related Groups in Russia in 2020. Medicinskie tekhnologii. Ocenka i vybor. 2020;39(1):19-29. (In Russ.).
  9. Gordev SS, Avxentyeva MV, Ledovskikh YuA, Tryakin AA, Fedyanin MYu, Mamedli ZZ, et al. Inpatient care: the evolution of payment methods and their impact on quality. Prakticheskaya onkologiya. 2020;21(2):91-100. (In Russ.). https://doi.org/10.31917/2102091
  10. Sura MV, Avxentyeva MV, Omelyanovskiy VV, Fedyaev DV, Andreeva NS, Zateishchikov DA, et al. Clinical and economic justification of the implementation of the outpatient drug supply system for able-bodied patients with arterial hypertension in the Russian Federation. Medicinskie tekhnologii. Ocenka i vybor. 2014;16(2):42-54. (In Russ.).
  11. Dombrovskiy VS, Omelyanovskiy VV. Study of the adherence to treatment: evaluation criteria and terminology. Medicinskie tekhnologii. Ocenka i vybor. 2015;20(2):16-23. (In Russ.).
  12. Lee SQ, Raamkumar AS, Li J, Cao Yu, Witedwittayanusat K, Chen L, et al. Reasons for Primary Medication Nonadherence: A Systematic Review and Metric Analysis. Journal of Managed Care and Speciality Pharmacy. 2018;24(8):778-794.  https://doi.org/10.18553/jmcp.2018.24.8.778
  13. Lemstra M. Nwankwo C, Bird Y, Moraros J. Primary nonadherence to chronic disease medications: a meta-analysis. Patient Preference and Adherence. 2018;12:721-731.  https://doi.org/10.2147/PPA.S161151
  14. Puts MTE, Tu HA, Tourangeau A, Howell D, Fitch M, Springall E, et al. Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. Annals of Oncology. 2014;25(3):564-577.  https://doi.org/10.1093/annonc/mdt433
  15. Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj Ch, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. https://doi.org/10.1136/bmjopen-2017-016982
  16. Walsh CA, Cahir C, Tecklenborg S, Byrne C, Culbertson MA, Bennett KE. The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysis. British Journal of Clinical Pharmacology. 2019;85(11):2464-2478. https://doi.org/10.1111/bcp.14075
  17. Doklad ob osushchestvlenii gosudarstvennogo kontrolya (nadzora) v sfere ohrany zdorov’ya grazhdan i ob effektivnosti takogo kontrolya (nadzora) v 2019 godu. Federal’naya sluzhba po nadzoru v sfere zdravoohraneniya (Roszdravnadzor), 2020. Accessed May 25, 2021. (In Russ.). https://roszdravnadzor.gov.ru/spec/about/plans/documents/66146
  18. Federal’naya sluzhba po nadzoru v sfere zdravoohraneniya/Roszdravnadzor provel masshtabnuyu proverku regionov po l’gotnomu lekarstvennomu obespecheniyu grazhdan. Accessed January 25, 2021. (In Russ.). https://roszdravnadzor.gov.ru/news/17681
  19. Avxentyeva MV, Bogin VI, Derkach EV, Omelyanovskiy VV, Stenina MB, Tarakanov AV, et al. Drugs provided to breast cancer patients within the state programs of drug supply. Farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2016;9(3):8-18. (In Russ.). https://doi.org/10.17749/2070-4909.2016.9.3.008-018
  20. Tryakin AA, Fedyanin MYu, Pokataev IA, Petrovsky AV. Open questions of standard approaches in oncology. Prakticheskaya onkologiya. 2020;21(2):81-90. (In Russ.). https://doi.org/10.31917/2102081
  21. Ledovskikh YuA, Omelianovskiy VV, Pirova GI, Avksenteva MV. The application of registries of accounts ofmandatory medical insurance for analysis of compliance of anti-tumor treatment to clinical recommendations. Problemi socialnoi gigieni, zdravookhranenia i istorii meditsini. 2019;27(5):882-887. (In Russ.). https://doi.org/10.32687/0869-866X-2019-27-5-882-887
  22. Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y, et al. Association between adherence to national comprehensive cancer network treatment guidelines and improved survival in patients with colon cancer. Cancer. 2013;119(8):1593-601.  https://doi.org/10.1002/cncr.27935
  23. Visser BC, Ma Y, Zak Y, Poultsides GA, Norton JA, Rhoads KF. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB. 2012;14(8):539-547.  https://doi.org/10.1111/j.1477-2574.2012.00496.x
  24. Zhao B, Tsai C, Hunt KK, Blair SL. Adherence to surgical and oncologic standards improves survival in breast cancer patients. Journal of Surgical Oncoogyl. 2019;120(2):1481-1459. https://doi.org/10.1002/jso.25506
  25. Al Farhan HA, Algwaiz GF, Alzahrani HA, Alsuhaibani RS, Alolayan A, Abdelhafiz N, et al. Impact of GI Tumor Board on Patient Management and Adherence to Guidelines. Journal of Global Oncoogyl. 2018;4:1-8.  https://doi.org/10.1200/JGO.17.00164
  26. Ricci-Cabello I, Vásquez-Mejía A, Canelo-Aybar C, Niño de Guzman E, Pérez-Bracchiglione J, Rabassa M, et al. Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries. BMC. Health Services Research. 2020;20(1):920.  https://doi.org/10.1186/s12913-020-05753-x

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.